The LDL receptor defect in familial hypercholesterolemia. Implications for pathogenesis and therapy.

[1]  A. Yamamoto,et al.  Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Mahley,et al.  Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. , 1981, The Journal of biological chemistry.

[3]  M. Brown,et al.  Regulation of plasma cholesterol by lipoprotein receptors. , 1981, Science.

[4]  H. Mabuchi,et al.  Effects of ML-236b (compactin) on sterol synthesis and low density lipoprotein receptor activities in fibroblasts of patients with homozygous familial hypercholesterolemia. , 1981, The Journal of clinical investigation.

[5]  A. Soutar,et al.  Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[6]  T. Kita,et al.  Deficiency of low density lipoprotein receptors in liver and adrenal gland of the WHHL rabbit, an animal model of familial hypercholesterolemia. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. Brown,et al.  Saturation and suppression of hepatic lipoprotein receptors: a mechanism for the hypercholesterolemia of cholesterol-fed rabbits. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[8]  D. Bilheimer,et al.  Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[9]  A. Endo.  Biological and pharmacological activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase , 1981 .

[10]  Y. Chao,et al.  Autoradiographic localization of the sites of uptake, cellular transport, and catabolism of low density lipoproteins in the liver of normal and estrogen-treated rats. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Edwards,et al.  The metabolism of native and malondialdehyde-altered low density lipoproteins by human monocyte-macrophages. , 1981, Journal of lipid research.

[12]  M. Brown,et al.  Partial purification and characterization of the low density lipoprotein receptor from bovine adrenal cortex. , 1980, The Journal of biological chemistry.

[13]  C. Packard,et al.  Effects of cholestyramine on receptor-mediated plasma clearance and tissue uptake of human low density lipoproteins in the rabbit. , 1980, The Journal of biological chemistry.

[14]  Y. Chao,et al.  The estradiol-stimulated lipoprotein receptor of rat liver. A binding site that membrane mediates the uptake of rat lipoproteins containing apoproteins B and E. , 1980, The Journal of biological chemistry.

[15]  R. Mahley,et al.  Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. , 1980, Journal of lipid research.

[16]  M. Brown,et al.  The cholesteryl ester cycle in macrophage foam cells. Continual hydrolysis and re-esterification of cytoplasmic cholesteryl esters. , 1980, The Journal of biological chemistry.

[17]  R. Mahley,et al.  Receptor binding of cholesterol-induced high-density lipoproteins containing predominantly apoprotein E to cultured fibroblasts with mutations at the low-density lipoprotein receptor locus. , 1980, Biochemistry.

[18]  Y. Tsujita,et al.  WHHL‐Rabbit: a low density lipoprotein receptor‐deficient animal model for familial hypercholesterolemia , 1980, FEBS letters.

[19]  R Monaghan,et al.  Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[20]  R. Mahley,et al.  Cell surface receptor binding of phospholipid . protein complexes containing different ratios of receptor-active and -inactive E apoprotein. , 1980, The Journal of biological chemistry.

[21]  M. Brown,et al.  EVOLUTION OF THE LDL RECEPTOR CONCEPT–FROM CULTURED CELLS TO INTACT ANIMALS * , 1980, Annals of the New York Academy of Sciences.

[22]  Y. Watanabe.  Serial inbreeding of rabbits with hereditary hyperlipidemia (WHHL-rabbit). , 1980, Atherosclerosis.

[23]  H. G. Morgan,et al.  Cholestyramine promotes receptor-mediated low-density-lipoprotein catabolism. , 1980, The New England journal of medicine.

[24]  M. Brown,et al.  Hydrolysis and excretion of cytoplasmic cholesteryl esters by macrophages: stimulation by high density lipoprotein and other agents. , 1980, Journal of lipid research.

[25]  P. Edwards,et al.  Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  R. Mahley,et al.  Rapid hepatic clearance of the canine lipoproteins containing only the E apoprotein by a high affinity receptor. Identity with the chylomicron remnant transport process. , 1980, The Journal of biological chemistry.

[27]  R. Mahley,et al.  Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. , 1980, The Journal of biological chemistry.

[28]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[29]  Y. Chao,et al.  Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol. , 1979, The Journal of biological chemistry.

[30]  M. Brown,et al.  Increased binding of low density lipoprotein to liver membranes from rats treated with 17 alpha-ethinyl estradiol. , 1979, The Journal of biological chemistry.

[31]  D. Bilheimer,et al.  Cellular pathology of homozygous familial hypercholesterolemia. , 1979, The American journal of pathology.

[32]  M. Brown,et al.  Solubilization of the low density lipoprotein receptor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Packard,et al.  Receptor-mediated low density lipoprotein catabolism in man. , 1979, Journal of lipid research.

[34]  A. Attie,et al.  Tissue sites of degradation of low density lipoprotein: application of a method for determining the fate of plasma proteins. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[35]  S. Grundy,et al.  Elevated cholesterol and bile acid synthesis in a young patient with homozygous familial hypercholesterolemia. , 1979, The Journal of clinical investigation.

[36]  Richard G. W. Anderson,et al.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins , 1979, The Journal of cell biology.

[37]  M. Brown,et al.  Degradation of low density lipoprotein . dextran sulfate complexes associated with deposition of cholesteryl esters in mouse macrophages. , 1979, The Journal of biological chemistry.

[38]  S. Grundy,et al.  Metabolic studies in familial hypercholesterolemia. Evidence for a gene-dosage effect in vivo. , 1979, The Journal of clinical investigation.

[39]  A. Endo.  Monacolin K, a new hypocholesterolemic agent produced by a Monascus species. , 1979, The Journal of antibiotics.

[40]  Joseph L. Goldstein,et al.  Coated pits, coated vesicles, and receptor-mediated endocytosis , 1979, Nature.

[41]  M. Krieger,et al.  Demonstration of low density lipoprotein receptors in mouse teratocarcinoma stem cells and description of a method for producing receptor-deficient mutant mice. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[42]  A. Chait,et al.  Regulatory role of triiodothyronine in the degradation of low density lipoprotein by cultured human skin fibroblasts. , 1979, The Journal of clinical endocrinology and metabolism.

[43]  M. Brown,et al.  Low density lipoprotein receptors in bovine adrenal cortex. II. Low density lipoprotein binding to membranes prepared from fresh tissue. , 1979, Endocrinology.

[44]  M. Brown,et al.  Familial hypercholesterolemia: model for genetic receptor disease. , 1979, Harvey lectures.

[45]  M. Brown,et al.  Receptor-mediated uptake of lipoprotein-cholesterol and its utilization for steroid synthesis in the adrenal cortex. , 1979, Recent progress in hormone research.

[46]  M. Brown,et al.  The LDL receptor locus and the genetics of familial hypercholesterolemia. , 1979, Annual review of genetics.

[47]  M. Brown,et al.  Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[48]  M. Krieger,et al.  Reconstituted low density lipoprotein: a vehicle for the delivery of hydrophobic fluorescent probes to cells. , 1979, Journal of supramolecular structure.

[49]  R. Mahley,et al.  Role of lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts. , 1978, The Journal of biological chemistry.

[50]  M. Brown,et al.  Familial hypercholesterolemia: pathogenesis of a receptor disease. , 1978, The Johns Hopkins medical journal.

[51]  M. Krieger,et al.  Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle. , 1978, The Journal of biological chemistry.

[52]  M. Brown,et al.  Characterization of the low density lipoprotein receptor in membranes prepared from human fibroblasts. , 1978, The Journal of biological chemistry.

[53]  J. Fryns,et al.  PRENATAL DIAGNOSIS OF HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLÆMIA Expression of a Genetic Receptor Disease in Utero , 1978, The Lancet.

[54]  K.,et al.  Genetics of the low density lipoprotein receptor. Diminished receptor activity in lymphocytes from heterozygotes with familial hypercholesterolemia. , 1978, The Journal of clinical investigation.

[55]  R. Mahley,et al.  Properties of lipoproteins responsible for high affinity binding to cell surface receptors of fibroblasts and smooth muscle cells. , 1978, Advances in Experimental Medicine and Biology.

[56]  A. Soutar,et al.  Simultaneous measurement of apolipoprotein B turnover in very-low-and low-density lipoproteins in familial hypercholesterolaemia. , 1977, Atherosclerosis.

[57]  M. Brown,et al.  Atherosclerosis: the low-density lipoprotein receptor hypothesis. , 1977, Metabolism: clinical and experimental.

[58]  N. Stone,et al.  Genetics of the LDL receptor: Evidence that the mutations affecting binding and internalization are allelic , 1977, Cell.

[59]  R. Mahley,et al.  Inhibition of lipoprotein binding to cell surface receptors of fibroblasts following selective modification of arginyl residues in arginine-rich and B apoproteins. , 1977, The Journal of biological chemistry.

[60]  J. Dietschy,et al.  Regulation of sterol synthesis in 15 tissues of rat. II. Role of rat and human high and low density plasma lipoproteins and of rat chylomicron remnants. , 1977, The Journal of biological chemistry.

[61]  T. Spinks,et al.  Non-stedy-state studies of low-density-liproprotein turnover in familial hypercholesterolaemia. , 1977, Clinical science and molecular medicine.

[62]  P. W. Adams,et al.  The effect of cholestyramine on the faecal excretion of bile acids and neutral steroids in familial hypercholesterolaemia. , 1977, Atherosclerosis.

[63]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[64]  D. Bilheimer,et al.  Regulation of low density lipoprotein receptor activity in freshly isolated human lymphocytes. , 1976, The Journal of clinical investigation.

[65]  J. Goldstein,et al.  Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus , 1976, Cell.

[66]  M. Brown,et al.  Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[67]  H. G. Morgan,et al.  Low density lipoprotein metabolism in a family of familial hypercholesterolemic patients. , 1976, Metabolism: clinical and experimental.

[68]  M. Brown,et al.  Evidence for regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and cholesterol synthesis in nonhepatic tissues of rat. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[69]  J. Smith,et al.  Malondialdehyde formation as an indicator of prostaglandin production by human platelets. , 1976, The Journal of laboratory and clinical medicine.

[70]  R. Mahley,et al.  Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts. , 1976, The Journal of biological chemistry.

[71]  S. Grundy,et al.  Reduction in cholesterol and low density lipoprotein synthesis after portacaval shunt surgery in a patient with homozygous familial hypercholesterolemia. , 1975, The Journal of clinical investigation.

[72]  J. Goldstein,et al.  Regulation of the activity of the low density lipoprotein receptor in human fibroblasts , 1975, Cell.

[73]  S. Srinivasan,et al.  Lipoprotein-acid mucopolysaccharide complexes of human atherosclerotic lesions. , 1975, Biochimica et biophysica acta.

[74]  L. Simons,et al.  The metabolism of the apoprotein of plasma low density lipoprotein in familial hyperbetalipoproteinaemia in the homozygous form. , 1975, Atherosclerosis.

[75]  M. Brown,et al.  Genetic heterogeneity in familial hypercholesterolemia: evidence for two different mutations affecting functions of low-density lipoprotein receptor. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[76]  M. Brown,et al.  Familial hypercholesterolemia. A genetic regulatory defect in cholesterol metabolism. , 1975, The American journal of medicine.

[77]  M. Marion.  The Familial Hyperlipoproteinemias , 1975 .

[78]  R. Havel,et al.  Lipoproteins and lipid transport. , 1975, Advances in experimental medicine and biology.

[79]  M. Brown,et al.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[80]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[81]  S. Grundy.  Treatment of Hypercholesterolemia by Interference With Bile Acid Metabolism , 1972 .

[82]  R. Levy,et al.  The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. , 1972, The Journal of clinical investigation.

[83]  D. Blankenhorn,et al.  The inheritance of familial hypercholesterolemia. , 1972, The American journal of medicine.

[84]  D. Bilheimer,et al.  The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations. , 1972, Biochimica et biophysica acta.

[85]  A. Khachadurian.  A General Review of Clinical and Laboratory Features of Familial Hypercholesterolemia (Type II Hyperbetalipoproteinemia) , 1972 .

[86]  J. Dietschy,et al.  Regulation of cholesterol metabolism. , 1970, The New England journal of medicine.

[87]  J. Dietschy,et al.  Regulation of cholesterol metabolism. I. , 1970, The New England journal of medicine.